43 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
171
Perk inhibiting compounds

Hibercell
84
SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF

Sanofi
108
3-[(1H-PYRAZOL-4-YL)OXY]PYRAZIN-2-AMINE COMPOUNDS AS HPK1 INHIBITOR AND USE THEREOF

BeiGene
37
ANTIBODY-DRUG CONJUGATES COMPRISING GLP1 PEPTIDOMIMETICS AND USES THEREOF

Regeneron Pharmaceuticals
417
Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof

Genentech
1
CRYSTALLINE FORMS OF (4S)-24-CHLORO-4-ETHYL-73-FLUORO-35-METHOXY-32,5-DIOXO-14-(TRIFLUORO-METHYL)-32H-6-AZA-3(4,1)-PYRIDINA-1(1)-[1,2,3]TRIAZOLA-2(1,2),7(1)-DIBENZENAHEPTAPHANE-74-CARBOXAMIDE

Bayer Aktiengesellschaft
162
Nitrogen-Containing Heterocyclic Compound, Pharmaceutical Compositions thereof and Use thereof

280 Bio
253
Imino sulfanone inhibitors of ENPP1

Volastra Therapeutics
64
Therapeutic agent for non-motor symptoms associated with Parkinson's disease

Sumitomo Pharma
52
Imidazole and triazole containing bicyclic compounds as JAK inhibitors

Theravance Biopharma R&D Ip
780
Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors

Forma Therapeutics
61
Macrocyclic compounds that inhibit MCL-1 protein

Amgen
11
Fused imidazo-piperidine JAK inhibitors

Theravance Biopharma R&D Ip
223
Macrocyclic compounds for treatment of medical disorders

Achillion Pharmaceuticals
129
CXCR7 antagonists

Chemocentryx
11
Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor

Bristol Myers Squibb
110
Oxadiazolones as transient receptor potential channel inhibitors

Genentech
19
Epoxyketone compounds for enzyme inhibition

Centrax International
26
Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereof

Guangzhou Maxinovel Pharmaceuticals
9
[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereof

Santen Pharmaceutical
20
Pyrrolo[2,3-d]pyrimidine compound or salt thereof

Taiho Pharmaceutical
369
Metallo-beta-lactamase inhibitors

Merck Sharp & Dohme
115
Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitors

Bristol Myers Squibb
116
Protein kinase C inhibitors and methods of their use

Novartis
57
Alpha-carbolines for the treatment of cancer

Universita Degli Studi Di Milano—Bicocca
177
Indole and indazole compounds that activate AMPK

Pfizer
11
Carbonic anhydrase inhibitors: in vitro inhibition of a isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids.

Ondokuz Mayis University
34
Bicyclic substituted pyrimidine compounds

Xuanzhu Pharma
82
Compositions and methods for the treatment of malaria

Saint Louis University
29
5-HT3 receptor antagonists

Takeda Pharmaceutical
5
Optically pure benzyl-4-chlorophenyl-C-glucoside derivative

Xuanzhu Pharma
22
Triazolopyridinone PDE10 inhibitors

Merck Sharp & Dohme
12
Functional reversal of (-)-Stepholidine analogues by replacement of benzazepine substructure using the ring-expansion strategy.

Fudan University
23
Tricyclic heterocyclic compounds

Bristol Myers Squibb
5
Compounds and methods for purification of serine proteases

Portola Pharmaceuticals
22
Inhibition of memapsin 1 cleavage in the treatment of diabetes

Oklahoma Medical Research Foundation
28
Selective caspase inhibitors and uses thereof

Novagenesis Foundation
20
Discovery of isoalloxazine derivatives as a new class of potential anti-Alzheimer agents and their synthesis.

The M. S. University of Baroda
10
Pyridinedione carboxamide inhibitors of endothelial lipase

Bristol Myers Squibb
111
Aminopyrazole derivative

Chugai Seiyaku Kabushiki Kaisha
5
Thieno[3,2-C]pyridine kinase inhibitors with improved CYP safety profile

Abbvie
8
Photoaffinity labeling of the Ah receptor.

University of Wisconsin
16
Somatostatin and its receptor family.

Royal Victoria Hospital